RxDoctor Payments Data

Clint Fenton, PA

Physician Assistant · Savannah, GANPI 1093205957

Payments from drug & device makers

$8,661in general payments, 2019–2025

Across 115 payments — averaging $75.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$4K
  • Biosense Webster, Inc.$3K
  • Sanofi-aventis U.S. LLC$609
  • Medtronic$505
  • E.r. Squibb & Sons, L.L.C.$304
  • Johnson & Johnson$290
  • plus $678 from 9 others

What the payments were for

  • Consulting fees$6,27572%
  • Food & beverage$2,38628%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,661 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$30,337
Medicare patients
273
Services billed
615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban1,050$861,157
XareltoRivaroxaban201$164,059
Dofetilide391$67,733
MultaqDronedarone Hcl73$60,265
Flecainide Acetate215$7,343
Diltiazem 24hr Er (Cd)Diltiazem Hcl219$5,020
Metoprolol Succinate264$3,781
Amiodarone Hcl213$3,563
Potassium Chloride155$2,320
Metoprolol Tartrate182$1,114
Diltiazem Hcl119$1,021
Klor-Con M20Potassium Chloride45$1,003
Losartan Potassium50$655
Cartia XtDiltiazem Hcl26$622
Diltiazem 24hr Er (Xr)Diltiazem Hcl11$421

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$27$861,1571,050 claims
Johnson & JohnsonXarelto$290$164,059201 claims
Sanofi-aventis U.S. LLCMultaq$609$60,26573 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →